|Articles|March 9, 2021
Biologics Contract Development and Manufacturing Services
Author(s)Emergent BioSolutions
Contract development and manufacturing (CDMO) services with support for mammalian, microbial, viral, plasma, and gene therapy.
Emergent BioSolutions is a global life sciences company whose mission is to protect and enhance life. Since 1998, Emergent BioSolutions has been a go-to source for solving some of the most complex and critical challenges in public health. From initial R&D and clinical studies to formulation, manufacturing and packaging, our experienced CDMO team at Emergent is ready to serve as your trusted guide from molecule to market.
Emergent BioSolutions
Related Content
Trending on Pharmaceutical Technology
1
The FDA Moves to Modernize Drug Manufacturing Registration
2
The Implications of Isatuximab-irfc’s FDA Approval for Multiple Myeloma
3
What the Ocrelizumab Deal Does for the Multiple Sclerosis Biosimilar Pipeline
4
It’s Time to Build a More Scalable, Connected CRO
5